Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal mucosal barrier and motility represent a complex physiological system essential for maintaining gastrointestinal homeostasis and systemic health. The mucosal barrier consists of a physical layer of mucus and epithelial cells connected by tight junctions, which selectively allow nutrient absorption while preventing the translocation of pathogens and toxins into the bloodstream (Source: PubMed, PMID: 23524162). Intestinal motility refers to the coordinated contraction and relaxation of smooth muscles, governed by the enteric nervous system, to move luminal contents through the digestive tract (Source: StatPearls, NBK553060). Dysregulation of these processes is central to the pathogenesis of various conditions, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and celiac disease. Therapeutic interventions often target specific components of this system, such as tight junction regulators to decrease permeability or receptor agonists/antagonists to modulate transit time and secretion (Source: NIH, PMC4253991).
Drugs targeting this system act through various mechanisms including the modulation of tight junction proteins (e.g., zonulin antagonism), activation of chloride channels or guanylate cyclase-C to increase secretion and motility, and agonism of opioid or serotonin receptors to regulate peristaltic speed.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal mucosal barrier and motility.